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Objectives: To report on a workshop, and subsequent discussions, that reviewed the
achievements and progress of the EuroScan collaboration since its establishment in 1999
to share information on the methods and results of early identification and assessment of
new and emerging health technologies; considered challenges to the collaboration; and
discussed its possible future direction.
Methods: A workshop was held in Stockholm in September 2006, with thirty-two
participants from ten countries and representatives from EuroScan member agencies,
policy makers involved in policy or decision making relating to new technologies, and
invited external commentators from international HTA networks. The workshop used a mix
of presentations, panel and audience discussions, and small group work to consider the
achievements and challenges put forward.
The meeting was supported by the Swedish Council on Technology Assessment in Health Care (SBU) and EuroScan. We thank Professor Per Carlsson of
the Center for Medical Technology Assessment, Linko¨ping University, Sweden, for initiating the workshop and providing the momentum for bringing it to
fruition. We also thank the Swedish Council on Technology Assessment in Health Care (SBU) and those members of SBU who gave their time before, during
and after the workshop, particularly Christina Engstro¨m, Peter Bjo¨rkegren, and Margereta Nordwall Ghetu. Without their help, the meeting would not have
been possible.
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EuroScan collaboration: achievements and challenges
Results: EuroScan has developed as a sustainable network, and has made progress on
all tasks in its initial action plan, with the EuroScan information sharing database on new
and emerging technologies being one of the collaboration’s key achievements. Identified
immediate concerns for the network included consideration of the impact of its current
name and membership model; acknowledgement and publication of the full range of
benefits of membership; contribution to and development of the database to encourage
increased information sharing; and EuroScan’s ongoing interaction with the wider HTA
world.
Conclusions: The workshop was a useful mechanism for reviewing the work of EuroScan
and for creating a platform to take the collaboration forward. The workshop affirmed the
benefits of the network to individual members; posed some significant challenges to the
network to consider; and acted as a stimulus for an interim name change to better
represent the global membership, and a major review of the EuroScan database of
identified and assessed emerging health technologies.
Keywords: Early warning systems, Horizon scanning, Health technology assessment,
Forecasting, Technology assessment, Biomedical, Diffusion of innovation
The early identification, prioritization, and assessment of
new or emerging health technologies (sometimes called early
warning or horizon scanning activities) has become an es-
sential part of the health technology assessment (HTA) and
policy decision-making processes (1). Over the last 20 to
30 years early identification and assessment systems have
been developed in many health and HTA systems within Eu-
rope and across the world. In the early 1990s, the feasibility
and benefits of an international network of horizon scanning
systems was discussed, and in 1993, an ultimately unsuc-
cessful proposal to establish a European system for early
identification of emerging healthcare technologies was sub-
mitted to the European Commission’s EUR-ASSESS pro-
gram. Following this, in January 1995 the Danish Hospital
Institute organized a meeting, the “International Collabora-
tion Concerning Monitoring of Emerging Medical Technolo-
gies.” Fourteen participants from Denmark, Finland, France,
Luxembourg, the Netherlands, Sweden, and the United
Kingdom discussed national experiences and the possibil-
ity of European collaboration.
The next major development took place in 1997 at an
international workshop held in Copenhagen “Scanning the
Horizon for Emerging Health Technologies.” The workshop
was supported by the Danish Institute for Health Technology
Assessment, the Swedish Council on Technology Assess-
ment in Health Care (SBU), and the European Commission
DGV, as part of the “Health Technology Assessment Eu-
rope” project. It attracted twenty-seven policy makers and
researchers from twelve countries. The workshop strongly
recommended collaboration and coordination among agen-
cies, with activities focused primarily on sharing informa-
tion, identifying relevant technologies, defining terminology,
and developing methods for early assessment. The work-
shop identified different levels of collaboration from a sim-
ple “mail-box” to exchange information produced nationally,
through an international network with shared briefings and
methods, to an international early identification and assess-
ment centre with no national centers (2;3). Acknowledging
that the proposals were ambitious, the workshop members
proposed that any collaboration should develop as a gradual
process with representatives from different countries start-
ing by establishing a “mail-box” to exchange findings, and
gradually advancing the cooperation to higher levels.
Following the workshop in Copenhagen, a small work-
ing group with representatives from Denmark, England, the
Netherlands, Spain, and Sweden, and associated representa-
tives from Canada and Switzerland, met in early 1998 and
agreed to set up a collaboration that was to become the Eu-
ropean Information Network on New and Emerging Health
Technologies (EuroScan). The aim of the new collabora-
tion was to enhance the exchange of information on new
and emerging technologies amongst members. By October
1999, EuroScan was formally established with agreed by-
laws, membership criteria, an Executive Committee, mem-
bership subscriptions and a Secretariat. Membership was
opened to any agency that had a substantial program for
the early identification and assessment of emerging, new, or
emerging health technologies; an ongoing, officially recog-
nized role in relation to regional or national government;
and was non-profit making with at least 50 percent funding
from public sources. By the end of December 2007 the net-
work had fifteen member agencies from thirteen countries
(Table 1).
In September 2006, EuroScan held a workshop to re-
view our progress and explore the next steps for the collabo-
ration. The workshop was a product of ongoing discussions
about the future direction of EuroScan and in light of other
European and global HTA-related collaborations and initia-
tives, including the European Network for Health Technol-
ogy Assessment (EUnetHTA), The International Network of
Agencies for Health Technology Assessment (INAHTA) and
Health Technology Assessment International (HTAi), Eu-
roScan in collaboration with SBU held a workshop to review
progress and to explore the next steps for the collaboration.
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Table 1. EuroScan Members in 1999 and 2007
Members in December 1999 Members by December 2007
◦ Agencia de Evaluacion de Tecnologias Sanitarias, Spain
(AETS)
◦ Agencia de Evaluacio´n de Technologı´as Sanitarias de
Andalucı´a, Spain (AETSA)
◦ Basque Office for Health Technology Assessment, Spain
(Osteba)
◦ Agencia de Evaluacion de Tecnologias Sanitarias, Spain
(AETS)
◦ Canadian Coordinating Office for HTA (CCOHTA) ◦ Australia and New Zealand Horizon Scanning Network
(ANZHSN)
◦ Committee for Evaluation & Diffusion of Innovative
Technologies, Paris (CEDIT)
◦ Basque Office for Health Technology Assessment, Spain
(Osteba)
◦ Danish Institute for HTA (DIHTA) ◦ Canadian Agency for Drugs and Technologies in Health
(CADTH)
◦ Health Council of the Netherlands (GR) ◦ Committee for Evaluation & Diffusion of Innovative
Technologies, Paris (CEDIT)
◦ National Horizon Scanning Centre, England (NHSC) ◦ Danish Centre for Evaluation and Health Technology
Assessment (DACEHTA)
◦ Norwegian Centre for Health Technology Assessment (SMM) ◦ Division of Medical Technology Policy, Israel (DMTP)
◦ Swedish Council on Technology Assessment in Health Care
(SBU)
◦ Finnish Office for HTA – Managed Uptake of Medical Methods
programme (MUMM)
◦ Swiss Federal Office of Social Security (SFOSS) ◦ Haute Autorite´ de Sante´, France (HAS)
◦ Health Council of the Netherlands (GR)
◦ National Horizon Scanning Centre, England (NHSC)
◦ Norwegian Knowledge Centre for the Health Services (NOKC)
◦ Swedish Council on Technology Assessment in Health Care
(SBU)
◦ Swiss Federal Office of Public Health (SFOPH)
The specific objectives of the workshop were:
• To share the progress, experiences and achievements in the early
identification and assessment of new and emerging health tech-
nologies within the EuroScan collaboration since 1998,
• To consider potential challenges for EuroScan to meet in the
future,
• To consider EuroScan’s future roles, goals, and collaborations,
and
• To develop a plan of action for international collaboration in
early warning activities for the future.
PARTICIPANTS AND METHODS
All EuroScan members were invited and were each asked to
invite interested policy makers involved in health policy or
decision making relating to new technologies in their coun-
try. Three external commentators were invited to comment
on EuroScan’s achievements in relation to initial expecta-
tions, to pose questions and challenges about EuroScan’s
relationship with other international projects, and comment
on its possible future direction. The commentators were Dr.
Berit Mørland (Norwegian Knowledge Centre for the Health
Services and, the then, President of HTAi), Professor Finn
Børlum Kristensen (Danish Centre for Evaluation and Health
Technology Assessment, and Project Leader for EUnetHTA),
and Professor Guy Maddern (Australian Safety and Efficacy
Register of New Interventional Procedures – Surgical, and
Chair of INAHTA).
The workshop included presentations of EuroScan’s
background, original objectives, achievements, and current
concerns; three countries’ perspectives of the influence of
early identification work on policy makers and systems; the
external commentators view of EuroScan’s achievements,
challenges, and possible direction; panel and audience dis-
cussions of issues highlighted in the presentations; and small
group work to consider the challenges posed and possible
future directions for EuroScan. Small groups were free to
use techniques such as analysis of strengths, weaknesses,
opportunities, and threats (SWOT analysis), and consensus
methods. Free-standing educational presentations on meth-
ods used in technology foresight and pharmaco-genomics
were included to break up the discussions and small group
sessions.
Findings
The workshop was held with thirty-two participants from
ten countries (Appendix 1). Participants included seventeen
staff from EuroScan member agencies and two invited policy
makers; the remainder were invited speakers or commenta-
tors, and observers from SBU.
EUROSCAN – PROGRESS, EXPERIENCES,
AND ACHIEVEMENTS
Original Objectives
In 1999 EuroScan members, in line with the recommenda-
tions from the 1997 Copenhagen workshop, agreed that its
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Table 2. 1999 Action Plan and Current Status (see http://www.euroscan.bham.ac.uk for More Information on the EuroScan
Collaboration and the Current Executive Committee)
Task Description Status
Task 1 Establish a common terminology, classification and
understanding of the activity
Common terminology agreed.
Task 2 Identify, evaluate and monitor the quality of sources of
information concerning new and emerging health
technologies
Ongoing. Discussed sources & prioritization criteria.
Members co-authored and contributed to a paper on the
use of the Internet for identification (4).
Task 3 Share methods for the early assessment of new and emerging
health technologies
Ongoing. Methods and changes to methods are discussed at
each meeting.
Task 4 Pilot the exchange of information on significant new and
emerging health technologies
Complete. Initially on paper at meetings, later by email.
Task 5 Establish a common database of significant new and
emerging health technologies
Pilot phase complete. Web-based database established in
2001. Over 1,000 entries by December 2007 (484 drugs,
260 devices, 97 diagnostics and 167 procedures). Public
search facility added with Web links to member’s
published reports.
Task 6 Publish and disseminate the results of these activities





•2000 co-hosted symposium with CCOHTA.
ISTAHC and HTAi conference presentations.
Status report published in January 2005. Web site is regularly
updated.
Task 7 Identify areas for further international research on early
warning activities and systems
Ongoing. Participation in a survey of criteria for selection of
new health technologies (5). International diffusion study
completed and published (7). Effective early warning
systems evaluation completed and published (6).
Task 8 Based on these experiences design and implement a
permanent system
Ongoing
aISTAHC, International Society of Technology Assessment in Health Care
long-term aim was to establish a permanent network among
agencies and organizations in the field of HTA to (i) evaluate
and exchange information on new and emerging technolo-
gies, (ii) develop the sources of information used, (iii) share
applied methods for early assessment, and (iv) to disseminate
information on early identification and assessment activities.
In 1999 EuroScan members agreed an initial action plan
with a timeframe of 2–3 years to promote these long-term
aims.
Workshop participants agreed that EuroScan has devel-
oped as a sustainable network that includes members outside
Europe, and that the collaboration has made progress on all
tasks in its initial action plan (Table 2), with the EuroScan
database on new and emerging technologies as one of the
collaboration’s key achievements. Other benefits of the col-
laboration were recognized:
• A supportive network of key individuals with biannual meetings
since 1998, individual email contacts and a members’ newsletter.
• Facilitation of sharing information on relevant methods and sys-
tems for early identification and early assessment activities, and
on policy-making customers’ needs.
• Guidance to member and nonmember agencies when developing
or reviewing early identification and early assessment systems.
• Improving the credibility and giving legitimacy to early warning
activities by supporting and raising the awareness of early iden-
tification, prioritization and assessment activities. The network
(and its constituent member agencies) has participated as experts
in early warning activities in international collaborations includ-
ing INAHTA, the European Collaboration for Health Technology
Assessment (ECHTA) and EUnetHTA.
• Improving the efficiency of early warning activities with links
globally to reduce duplication, increase the reliability of output,
and assist members with limited resources.
• Although not specifically funded to undertake research, the net-
work has acted as a network for developing methods and for sup-
porting research on early identification and assessment methods
and activities (4–7).
INFLUENCE ON POLICY MAKERS AND
SYSTEMS: 3 COUNTRIES’ EXPERIENCES
During the workshop, participants from three countries dis-
cussed and gave examples of how information from early
identification and assessment systems impacts on policy and
decision making. The countries were chosen as their early
identification systems were known to be linked closely with
policy decisions.
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England
The National Horizon Scanning Centre (NHSC) in England
identifies emerging technologies for final prioritization by
national policy makers for the development of guidance to
the health service, and for further research or assessment.
Policy-making customers include the National Institute for
Health and Clinical Excellence (NICE), the HTA research
program, the National Screening Committee, and the Centre
for Evidence-Based Purchasing (a medical device evaluation
service). The NHSC is critical to the work of NICE, with new
technologies identified and prioritized by the NHSC making
up a significant part of NICE’s appraisal program. In addi-
tion, having NICE as a customer is critical to the NHSC,
and enables information on significant emerging health tech-
nologies to be used by policy makers in a timely manner.
Research on the adoption and diffusion of new health tech-
nologies carried out by the NHSC is important in helping
to predict how new technologies introduced into the health
service will behave.
The Basque Country
SorTek, the early warning system established in 2000 for
the Basque Office for HTA (Osteba), uses clinicians in over
twenty different specialties and policy makers to identify po-
tentially significant health technologies and to validate result-
ing early assessment reports. The Basque Country’s strategy
for dealing with new technologies differs from many regions
and countries in that technologies identified at an early stage
where evidence is weak, are subject to regulated introduc-
tion. This usually involves controlled use in a small number
of hospitals where the technology is subject to monitoring
and further research. A regulatory law for the introduction of
new and emerging nondrug technologies has been in place
since November 2004 and has helped to formalize the pro-
cess. There is evidence of the impact of the system in the
diffusion of health technologies when compared with other
autonomous regions in Spain. The network has established
contacts with other similar organizations within Spain to
share the methods and information gained.
Canada
The mix of federal, provincial, and territorial health care,
insurance systems, and decision making in Canada leads to
many challenges in the introduction of new health technolo-
gies, including regional variations in access and coverage.
The emerging health technologies program of the Canadian
Agency for Drugs and Technologies in Health (CADTH),
formalized in the late 1990s with its role in the early identifi-
cation and assessment of new technologies, was re-affirmed
by the 2004 Canadian Health Technology Strategy. The im-
pact of horizon scanning on policy making in Canada is
difficult to measure but appears to be appreciated as an in-
formation source for current awareness. CADTH’s emerging
technology publications are actively disseminated to Cana-
dian healthcare policy makers, and there is some indication
that these publications are also used by many other audiences.
EUROSCAN – CHALLENGES
The questions posed and challenges put forward by mem-
bers and the external commentators during the workshop
had some common themes:
• Audience for EuroScan activities
◦ Is the audience for EuroScan outputs individual researchers,
HTA agencies, policy makers, or clinicians?
◦ What do EuroScan members and stakeholders want from the
collaboration?
◦ Should EuroScan be communicating directly with policy
makers?
• Membership model
◦ Can EuroScan’s aims be met with a small focused group or
should it now encompass a wider group?
◦ Should there be different levels of membership depending
on contributions and use of the network and database?
◦ Is the Eurocentric name a hindrance to greater international
collaboration?
• EuroScan and other international networks
◦ What is the relationship between EuroScan, EUnetHTA,
HTAi, and INAHTA?
◦ Is there duplication between subscriptions or activities be-
tween these networks?
◦ Are there opportunities to reduce duplication or increase
collaboration?
• Methods and development of methods
◦ Can EuroScan continue to focus on both identification and
early assessment?
◦ Should EuroScan create subgroups to focus on methodolog-
ical topics and development?
◦ Should EuroScan undertake more methods development and
if so who will fund it?
◦ Who is the EuroScan database for, and who owns it and the
information within it?
• Working toward an international early warning system or center
◦ Is it time to work toward the establishment of a common
horizon scanning or early warning system or center?
◦ Does the difference in wants and needs between the funders
of the EuroScan member agencies mean that development of
a common global system will be impossible?
◦ Is it possible to collaborate more closely on identification,
prioritization, and/or early assessment—if not with all the
network, then with a subgroup of members?
These challenges and other questions arising during
panel discussions were discussed in smaller working groups.
During these discussions more questions and challenges were
generated, as well as some suggestions or exploratory actions
proposed.
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EUROSCAN – FUTURE ROLES, GOALS,
AND COLLABORATION
After the workshop the EuroScan Secretariat summarized
the identified challenges, suggestions, options and potential
solutions into similar groups for consideration. The cate-
gories covered the purpose and name of EuroScan; benefits
of membership of the network; the membership and sub-
scription model; collaboration in general and more specifi-
cally using the EuroScan database; early identification and
early assessment methods including working toward greater
collaboration; research and development activities and top-
ics; and EuroScan’s interaction with the wider HTA world.
Discussions on all sections have been taken forward over
subsequent EuroScan meetings with the view to developing
a new strategy and action plan.
Although the longer-term strategy is yet to be discussed
and agreed, some agreements and actions have already taken
place:
• The network agreed that its aims and objectives, and membership
criteria will remain the same.
• The benefits of membership in the network were affirmed and
posted on the EuroScan website. There was an acceptance that
individual member agencies contribute differentially to different
aspects of the collaboration, and that contributions should not be
measured solely by additions to the technology database.
• The network agreed that its focus will continue to include the
identification of potentially significant emerging health technolo-
gies, their selection and prioritization, and early assessment.
• In recognition of the global nature of the activity and the net-
work, and taking on board the concerns about its Eurocentric
name, the “long name” of the collaboration has been changed
from the “European Information Network on New and Emerging
Health Technologies” to the “International Information Network
on New and Emerging Health Technologies.” After discussion
and consideration of the current ‘branding’ of EuroScan as a
short name, the network decided to keep its short name, but will
change its logo to better reflect the global nature of its activities.
• The members use and contribution to the EuroScan database of
identified and assessed emerging health technologies has been
reviewed with a view to increasing contributions from members
who currently are low contributors.
• Since the workshop, the EuroScan database has been used as the
basis for the selection of topics for inclusion in the EUnetHTA
Working Party 7’s newsletter for European policy makers, and
is part of EuroScan’s contribution (as a collaborating partner) to
EUnetHTA.
CONCLUSIONS
As the horizon scanning workshop of 1997 was the con-
ception of EuroScan as an international network for collab-
oration on emerging and new health technologies, so the
workshop in 2006 was a useful mechanism for reviewing
the work of EuroScan over its 8 years of existence and for
creating a platform to take the collaboration forward. The
comments and challenges provided by members, other HTA
networks, and policy makers were invaluable. The workshop
affirmed the benefits of the network to individual members;
posed some significant challenges for the network to con-
sider; and acted as a stimulus for a major review of the Eu-
roScan database, an interim name change to better represent
the global membership, and ongoing debate of the benefits
of moving toward common methods and single outputs in
horizon scanning. The workshop re-affirmed the benefits of
developing and using common methodological approaches
and sharing of information of new and emerging health tech-
nologies set out in the 1997 workshop, and provided direction
for future discussions.
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Appendix 1. Participants
Name Position and organization Role
Dr. Ma Luisa Arteagoitia
Gonza´lez
Planning Director, Department of Health, Basque Government,
Spain
Invited policy maker
Dr. Eva Blozik Medical Technology Unit, Swiss Federal Office of Public Health
(SFOPH), Switzerland
EuroScan member agency
Dr. Finn Børlum Kristensen Director, Danish Centre for Evaluation and Health Technology
Assessment (DACEHTA)
Invited external commentator
Professor Per Carlsson Professor, Linko¨ping University; and Swedish Council on
Technology Assessment in Health Care (SBU)
EuroScan member agency
Helena Dahlgren Project Director, Swedish Council on Technology Assessment in
Health Care (SBU)
Observer
Ms. Anne-Florence Fay Assistance Publique-Hoˆpitaux de Paris, Committee for Evaluation
and Diffusion of Innovative Technologies (CEDIT), France
EuroScan member agency
Dr. Kees Groeneveld Health Council of the Netherlands (GR) EuroScan member agency
Dr. In˜aki Gutie´rrez
Ibarluzea
Basque Office for Health Technology Assessment (Osteba), Spain EuroScan Vice-Chair
EuroScan member agency
Dr. Ed Hunt Chair of Board, Canadian Agency for Drugs and Technologies in
Health (CADTH)
Invited external speaker
Professor Janet Hiller Head of Department, Department of Public Health, University of
Adelaide, and The Australian and New Zealand Horizon
Scanning Network (ANZHSN)
EuroScan member agency
Torben Jørgensen Health Technology Assessment Consulting Invited external speaker
Professor Brendon Kearney Chair, Health Policy Advisory Committee on Technology
(HPACT), Medical Services Advisory Committee, Australia
EuroScan member agency
Elin Kullerstrand Project Assistant, SBU Alert, Swedish Council on Technology
Assessment in Health Care (SBU)
Observer
Christoph Ku¨nzli Manager International Affairs, Medical Technology Unit, Swiss
Federal Office of Public Health (SFOPH), Switzerland
EuroScan member agency
Dr. Setefilla Luengo SINTESIS, Agencia de Evaluacion de Tecnologias Sanitarias
(AETS), Madrid, Spain
EuroScan member agency
Professor Guy Maddern Surgical Director, Australian Safety and Efficacy Register of New
Interventional Procedures – Surgical (ASERNIP-S)
Invited external commentator
Dr. Ruth March Senior Principal Scientist, AstraZeneca, England Invited external speaker
Dr. Berit Mørland Deputy Director General, Norwegian Knowledge Centre for the
Health Services (NOKC)
Invited external commentator
Isabel Narva´ez Project Manager, Spanish Observatory for Industrial and
Technological Prospective (OPTI)
Invited external speaker
Dr. Inger Norderhaug Research Director, HTA Reviews and Dissemination Department,
Norwegian Centre for Health Services Research (NOKC)
EuroScan member agency
Dr. Claire Packer Director, National Horizon Scanning Centre (NHSC), England EuroScan member agency and
Head of secretariat
Mrs. Kay Pattison Research and Development, Department of Health for England Invited policy maker
Professor N Rehnqvist Chair of SBU Board, Swedish Council on Technology Assessment
in Health Care (SBU)
Invited session chair
Professor Ma˚ns Rose´n Director of SBU, Swedish Council on Technology Assessment in
Health Care (SBU)
Observer
Professor Lars Ryde´n Professor Emeritus Cardiology, Swedish Council on Technology
Assessment in Health Care (SBU)
Invited session chair
Karin Rydin Research Coordinator, SBU Alert, Swedish Council on
Technology Assessment in Health Care (SBU)
Observer
Dr. Jill Sanders President and Chief Executive Officer, Canadian Agency for
Drugs and Technologies in Health (CADTH)
EuroScan Chair and EuroScan
member agency
Dr. Sue Simpson Euroscan Secretariat, National Horizon Scanning Centre (NHSC),
England
EuroScan member agency and
secretariat
Professor Andrew Stevens Director, National Horizon Scanning Centre (NHSC), England EuroScan member agency
Leigh-Ann Topfer Manager, Emerging Health Technologies, Canadian Agency for
Drugs and Technologies in Health (CADTH)
EuroScan member agency
Helene To¨rnqvist Director, SBU Alert, Swedish Council on Technology Assessment
in Health Care (SBU)
EuroScan member agency
Dr. Johan Wallin Project Director, SBU Alert, Swedish Council on Technology
Assessment in Health Care (SBU)
EuroScan member agency
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